A few moments ago, the United States Supreme Court stayed enforcement of the decision of Judge Matthew Kacsmaryk voiding the FDA’s approval of mifepristone in Alliance for Hippocratic Medicine v. FDA until April 19, 2023, when a new order from the Supreme Court is expected.
Comments
No posts